Human herpesvirus vaccines and future directions.
Am J Transplant
; 13 Suppl 3: 79-86; quiz 86, 2013 Feb.
Article
em En
| MEDLINE
| ID: mdl-23347216
ABSTRACT
Over the last few years there has been an impressive increase in the virological and immunological tools available to detect both human herpesvirus (HHV) and immune control of replication post-solid organ transplantation. This has allowed a greater appreciation of pathogenesis, studies to be designed to evaluate potential vaccines, new approaches adopted for antiviral deployment and the success of interventions to be judged. This chapter aims to summarize the state-of-the-art in vaccine development and look forward to the role that vaccines, immune monitoring, viral kinetics and new antiherpesvirus agents may play in the future management of HHV infections after transplantation.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Imunoterapia Adotiva
/
Transplante de Órgãos
/
Infecções por Citomegalovirus
/
Infecções por Herpesviridae
/
Vacinas contra Herpesvirus
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article